These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 29802210)
1. Neuroprotection via AT Bennion DM; Steckelings UM; Sumners C Clin Sci (Lond); 2018 May; 132(10):1055-1067. PubMed ID: 29802210 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of the angiotensin II AT Bennion DM; Jones CH; Dang AN; Isenberg J; Graham JT; Lindblad L; Domenig O; Waters MF; Poglitsch M; Sumners C; Steckelings UM Clin Sci (Lond); 2018 Mar; 132(5):581-593. PubMed ID: 29500223 [TBL] [Abstract][Full Text] [Related]
3. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage. Min LJ; Mogi M; Tsukuda K; Jing F; Ohshima K; Nakaoka H; Kan-No H; Wang XL; Chisaka T; Bai HY; Iwanami J; Horiuchi M Am J Hypertens; 2014 Aug; 27(8):1036-44. PubMed ID: 24572705 [TBL] [Abstract][Full Text] [Related]
4. Attenuation of stroke damage by angiotensin II type 2 receptor stimulation via peroxisome proliferator-activated receptor-gamma activation. Shan BS; Mogi M; Iwanami J; Bai HY; Kan-No H; Higaki A; Min LJ; Horiuchi M Hypertens Res; 2018 Oct; 41(10):839-848. PubMed ID: 30089862 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke. Bennion DM; Jones CH; Donnangelo LL; Graham JT; Isenberg JD; Dang AN; Rodriguez V; Sinisterra RDM; Sousa FB; Santos RAS; Sumners C Exp Physiol; 2018 Jun; 103(6):916-923. PubMed ID: 29663576 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice. Schwengel K; Namsolleck P; Lucht K; Clausen BH; Lambertsen KL; Valero-Esquitino V; Thöne-Reineke C; Müller S; Widdop RE; Denton KM; Horiuchi M; Iwai M; Boato F; Dahlöf B; Hallberg A; Unger T; Steckelings UM J Mol Med (Berl); 2016 Aug; 94(8):957-66. PubMed ID: 26983606 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important? Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 2 receptor agonists as therapies for ischemic stroke. Dorrance AM Hypertension; 2012 Dec; 60(6):1391-2. PubMed ID: 23090776 [No Abstract] [Full Text] [Related]
11. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667 [TBL] [Abstract][Full Text] [Related]
12. Recommendations and treatment strategies for the management of acute ischemic stroke. Segura T; Calleja S; Jordan J Expert Opin Pharmacother; 2008 May; 9(7):1071-85. PubMed ID: 18422467 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. McCarthy CA; Vinh A; Callaway JK; Widdop RE Stroke; 2009 Apr; 40(4):1482-9. PubMed ID: 19246705 [TBL] [Abstract][Full Text] [Related]
14. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Thériault P; Le Béhot A; ElAli A; Rivest S Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662 [TBL] [Abstract][Full Text] [Related]
15. Neuroserpin and Extracellular Vesicles in Ischemic Stroke: Partners in Neuroprotection? Brenna S; Glatzel M; Magnus T; Puig B; Galliciotti G Aging Dis; 2024 Oct; 15(5):2191-2204. PubMed ID: 39191396 [TBL] [Abstract][Full Text] [Related]
16. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model. Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586 [TBL] [Abstract][Full Text] [Related]
17. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT Justin A; Divakar S; Ramanathan M Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550 [TBL] [Abstract][Full Text] [Related]
18. Hi1a as a Novel Neuroprotective Agent for Ischemic Stroke by Inhibition of Acid-Sensing Ion Channel 1a. Ren Y; Li C; Chang J; Wang R; Wang Y; Chu XP Transl Stroke Res; 2018 Apr; 9(2):96-98. PubMed ID: 29027122 [TBL] [Abstract][Full Text] [Related]
19. Involvement of angiotensin-(1-7) in the neuroprotection of captopril against focal cerebral ischemia. Tao MX; Xue X; Gao L; Lu JL; Zhou JS; Jiang T; Zhang YD Neurosci Lett; 2018 Nov; 687():16-21. PubMed ID: 30219484 [TBL] [Abstract][Full Text] [Related]
20. Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats. McCarthy CA; Vinh A; Miller AA; Hallberg A; Alterman M; Callaway JK; Widdop RE PLoS One; 2014; 9(4):e95762. PubMed ID: 24752645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]